MYERS STEVEN S 4
4 · CALADRIUS BIOSCIENCES, INC. · Filed Dec 10, 2021
Insider Transaction Report
Form 4
MYERS STEVEN S
Director
Transactions
- Purchase
Common Stock
2021-12-08$0.89/sh+33,785$30,190→ 146,839 total
Holdings
- 8,434(indirect: By IRA)
Common Stock
- 1,954(indirect: By Trust)
Common Stock
- 802(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8802 to $0.9000, inclusive. The reporting person undertakes to provide Caladrius Biosciences, Inc., any security holder of Caladrius Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F2]Represents 37,735 unvested restricted stock awards granted under Issuer's 2018 Equity Incentive Compensation plan, which will vest on January 11, 2022.